Dionysios Prevezanos

Dr. Dionysios Prevezanos

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Christos DamaskosChristos Damaskos
Christos Damaskos
Nikolaos GarmpisNikolaos Garmpis
Nikolaos Garmpis
DDDimitrios Dimitroulis
Dimitrios Dimitroulis
AGANNA GARMPI
ANNA GARMPI
Iason PsilopatisIason Psilopatis
Iason Psilopatis
EAEfstathios A. Antoniou
Efstathios A. Antoniou
Hepatocellular carcinoma (HCC) remains one of the most common malignancies and the third cause of cancer-related death worldwide, with surgery being the best prognostic tool. Among the well-known causative factors of HCC are chronic liver virus infections, chronic virus hepatitis B (HBV) and chronic hepatitis virus C (HCV), aflatoxins, tobacco consumption, and non-alcoholic liver disease (NAFLD). There is a need for the development of efficient molecular markers and alternative therapeutic targets of great significance. In this review, we describe the general characteristics of HCC and present a variety of targeted therapies that resulted in progress in HCC therapy.

Verified
Journal Article
Open access
PDF file
Christos DamaskosChristos Damaskos
Christos Damaskos
Nikolaos GarmpisNikolaos Garmpis
Nikolaos Garmpis
DDDimitrios Dimitroulis
Dimitrios Dimitroulis
AGANNA GARMPI
ANNA GARMPI
EDEvangelos Diamantis
Evangelos Diamantis
GKGregory Kouraklis
Gregory Kouraklis
Long non-coding RNAs (lncRNAs) are transcripts of more than 200 nucleotides which cannot be translated into proteins. Small nucleolar RNA host gene 15 (SNHG15) is a lncRNA whose dysregulation has been found to have an important impact on carcinogenesis and affect the prognosis of cancer patients in various cancer types. Hepatocellular carcinoma (HCC) is one of the most common cancers with a poor long-term prognosis, while the best prognostic factor of the disease is its early diagnosis and surgery. Consequently, the investigation of the mechanisms of hepatocarcinogenesis, as well as the discovery of efficient molecular markers and therapeutic targets are of great significance. An extensive literature search was performed in MEDLINE in order to identify clinical studies that tried to reveal the role of SNHG15 in HCC. We used keywords such as ‘HCC’, ‘hepatocellular carcinoma’, ‘SNHG15’ and ‘clinical study’. Finally, we included four studies written in English, published during the period 2016–2021. It was revealed that SNHG15 is related to the appearance of HCC via different routes and its over-expression affects the overall survival of the patients. More assays are required in order to clarify the potential role of SNHG15 as a prognostic tool and therapeutic target in HCC.

9 January 2025 in Emergency Care and Medicine
Verified
Journal Article
Open access
PDF file
DPDionysios Prevezanos
Dionysios Prevezanos
CDChristos Doudakmanis
Christos Doudakmanis
Stamatios TheocharisStamatios Theocharis
Stamatios Theocharis
Stylianos KykalosStylianos Kykalos
Stylianos Kykalos
NNNikolaos Ioannis Nikiteas
Nikolaos Ioannis Nikiteas
GTGerasimos Tsourouflis
Gerasimos Tsourouflis
Background: Abnormalities in the canal of the Nuck are rare clinical entities with presentation in the early adulthood of females. Given their rarity, they can be misdiagnosed with a strangulated inguinal hernia. Methods: Herein, we report a young female with painful swelling of the right inguinal hernia and its surgical approach. Results: A 37-year-old female presented to the emergency department with pain in the right lower abdominal quadrant and an edematous inguinal mass. Physical examination showed a palpable inguinal mass, setting the suspicion for possible incarcerated inguinal hernia. Laboratory exams were within normal ranges. The patient was subsequently treated surgically. During the operation, a cystic well-rounded mass was identified and completely excised. The mesh and plug technique was the chosen technique for the restoration of the inguinal canal. The hospitalization length was one day, and the post-operative course was uneventful. Conclusions: Although a Nuck cyst is a rare entity, it should be taken into consideration in female adults who present with an inguinal mass.

6 March 2026 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
DPDionysios Prevezanos
Dionysios Prevezanos
DVDimitrios K Vlachos
Dimitrios K Vlachos
KCKonstantinos Chatzidimitriadis
Konstantinos Chatzidimitriadis
IZIoannis-Georgios Zacharias
Ioannis-Georgios Zacharias
SSStratigoula Sakellariou
Stratigoula Sakellariou
DMDimitrios Mantas
Dimitrios Mantas
Intestinal duplication cysts (IDCs) are rare congenital anomalies, most commonly arising in the small intestine. A particularly uncommon subtype, completely isolated duplication cysts (CIDCs), has an independent blood supply and lacks communication with the native bowel. Although IDCs are typically benign, malignant transformation—including low-grade mucinous neoplasms (LGMNs)—has been reported only rarely. A Caucasian male with a history of infant colostomy for ileus, later reversed, presented with an abdominal wall mass at the former stoma site. Imaging demonstrated a well-encapsulated cystic lesion originating above the posterior rectus sheath, and complete surgical excision was achieved uneventfully. Histopathology revealed a mucin-secreting epithelial lining with low-grade dysplasia, consistent with LGMN, with immunohistochemistry excluding alternative gastrointestinal neoplasms. The patient recovered without complications and showed no recurrence on follow-up. This represents the first documented CIDC with LGMN in the abdominal wall, highlighting the importance of early identification and surgical management.

23 April 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Christos DamaskosChristos Damaskos
Christos Damaskos
Nikolaos GarmpisNikolaos Garmpis
Nikolaos Garmpis
DLDimitrios Lamprinos
Dimitrios Lamprinos
GKGregory Kouraklis
Gregory Kouraklis
DPDionysios Prevezanos
Dionysios Prevezanos
EEEleni Efremidou
Eleni Efremidou
Background/Objectives: The surge in migration from the Middle East and North Africa due to conflicts has significantly impacted healthcare systems, particularly in Greece. This study investigates how the sharp increase in refugees and migrants after July 2015 has strained the surgical departments of the Greek National Health System (NHS). Methods: A retrospective analysis was conducted on 229 patients treated at the emergency department of a public hospital in Athens, Greece. Data were compared between two periods: January 2012–July 2015 (pre-July 2015) and July 2015–December 2018 (post-July 2015), with July 2015 chosen as the cutoff due to a significant influx of immigrants during that time. Results: Patients’ demographic details, diagnoses, and surgical interventions were analyzed. Results indicated a significant rise in surgical cases, with 72.5% of patients requiring procedures, notably for appendicitis (23.6%), cholecystitis (10.9%), lower extremity thrombophlebitis (9.6%), perianal abscess (8.3%), and inguinal hernia (5.7%). Post-July 2015, there was a notable increase in perianal abscess (12.2%), inguinal hernia (8.4%), and cholelithiasis (6.1%). However, the average hospital stay of 3.9 days remained unchanged. Conclusions: The findings reveal the profound economic and operational pressures on the NHS during the refugee crisis, highlighting the urgent need for resource optimization and policy reforms. Future studies should address long-term healthcare impacts to support more sustainable healthcare models amidst ongoing and future migration challenges.

Verified
Journal Article
Open access
PDF file
APAnna Paspala
Anna Paspala
DVDimitrios K. Vlachos
Dimitrios K. Vlachos
DPDionysios Prevezanos
Dionysios Prevezanos
PDPanagiotis Dorovinis
Panagiotis Dorovinis
Nikolaos MachairasNikolaos Machairas
Nikolaos Machairas
GSGeorgios Sotiropoulos
Georgios Sotiropoulos
Background/Objectives: Primary biliary neuroendocrine tumors (PBilNETs) are exceptionally rare biliary tract neoplasms that are frequently misdiagnosed preoperatively as cholangiocarcinoma because of overlapping clinical and radiological findings. This systematic review aimed to summarize overall evidence regarding presentation, diagnostic evaluation, surgical management, and outcomes of PBilNETs. Methods: A systematic search of PubMed, Scopus, and Embase databases was performed according to PRISMA guidelines for studies published between January 2000 and December 2025. Studies including adult patients with histologically confirmed and surgically treated PBilNETs were eligible. Data regarding demographics, symptoms, imaging findings, surgical treatment, histopathology, immunohistochemistry, and outcomes were extracted and analyzed. Results: Fifty-eight studies involving 79 patients met the inclusion criteria. Median age at diagnosis was 49 years, with female predominance. Obstructive jaundice, abdominal pain, and pruritus were the most common presenting symptoms. Most tumors originated from the hilar or extrahepatic bile ducts. Preoperative diagnosis was challenging, as most lesions were initially considered cholangiocarcinomas. Surgical resection was the main therapeutic approach and included bile duct excision with biliary reconstruction, pancreaticoduodenectomy, or hepatic resection according to tumor location. Histopathological analysis demonstrated predominantly well- or moderately differentiated neuroendocrine neoplasms with frequent chromogranin A and synaptophysin positivity. Favorable long-term outcomes were reported, with high postoperative survival and limited recurrence during follow-up. Conclusions: PBilNETs remain diagnostically challenging because of their rarity and nonspecific presentation; however, they appear to exhibit a less aggressive biological behavior than conventional biliary adenocarcinomas. Surgical resection remains the cornerstone of treatment, while further multicenter studies are required to optimize diagnostic and therapeutic strategies. The findings also support an individualized multidisciplinary approach integrating clinical presentation, advanced imaging, histopathological grading, and immunohistochemical profiling to optimize personalized management of these rare tumors.